Nano Science and Technology InstituteNano Science and Technology Institute
Nano Science and Technology Institute 2005 NSTI Nanotechnology Conference & Trade Show
Nanotech 2005
Bio Nano 2005
Business & Investment
Nano Impact Workshop
Program
Sessions
Sunday
Monday
Tuesday
Wednesday
Thursday
Index of Authors
Index of Keywords
Keynote Presentations
Confirmed Speakers
Participating Companies
Industry Focus Sessions
Nanotech Expo
Special Symposia
Conferences
Sponsors
Exhibitors
Venue 2005
Organization
Press Room
Subscribe
Site Map
Nanotech 2005 At A Glance
Nanotech Proceedings
Nanotechnology Proceedings
Global Partner
nano tech
Supporting Organizations
Nanotech 2005 Supporting Organization
Media Sponsors
Nanotech 2005 Medias Sponsors
Event Contact
696 San Ramon Valley Blvd., Ste. 423
Danville, CA 94526
Ph: (925) 353-5004
Fx: (925) 886-8461
E-mail:
 
 

Peptide Based Nanoparticles as a Platform for Vaccine Design

S.K. Raman, D.J. Kao, D. Tropel, A. Graff, G. Machaidze, R.S. Hodges and P. Burkhard
Biozentrum, CH

Keywords:
vaccine design, nanoparticle, self-assembly, immunology

Abstract:
To-date vaccines for many of the dreadful diseases such as Tuberculosis, Malaria, AIDS and Hepatitis are still ineffective or unavailable. Peptide based vaccines have been developed but because of their poor immunogenic response and the toxicity issue of the adjuvants used along with peptides still remains a concern. Here we describe the structure-based design of peptidic nanoparticles with regular polyhedral symmetry that mimic the architecture of viruses. Such peptide based nanoparticles represent an ideal repetitive antigen display system and may be used as a platform for the design of synthetic vaccines. Repetitive antigen display has been shown to strongly increase the immunogenicity of a given epitope and novel vaccines based on virus-like particles are gaining increased interest in the field of vaccine design. To validate our system as a novel platform for vaccine design, we have designed nanoparticles that display antigenic sequences at their surface. As a test model we have inserted the pilin sequence from Pseudomonas at the C-terminus of the constructs. Immunization experiments of such different sized nanoparticles conjugated with the Pseudomonas pilin sequence (and also with other model surface antigens) in rabbits have recently been initiated.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors

Nanotech 2005 Conference Program Abstract

 
Gold Sponsors
Nanotech Gold Sponsors
Silver Sponsors
Nanotech Silver Sponsors
Gold Key Sponsors
Nanotech Gold Key Sponsors
Nanotech Ventures Sponsors
Nanotech Ventures Sponsors
Sponsors
Nanotech Sponsors
News Headlines
NSTI Online Community
 
 

© Nano Science and Technology Institute, all rights reserved.
Terms of use | Privacy policy | Contact